Werewolf Therapeutics, Inc. (HOWL)
0.9744
-0.01
(-1.43%)
USD |
NASDAQ |
Sep 11, 11:36
Werewolf Therapeutics Shareholders Equity (Quarterly) : 16.29M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.29M |
| March 31, 2026 | 12.20M |
| December 31, 2025 | 24.80M |
| September 30, 2025 | 29.61M |
| June 30, 2025 | 41.46M |
| March 31, 2025 | 57.31M |
| December 31, 2024 | 73.39M |
| September 30, 2024 | 89.38M |
| June 30, 2024 | 104.02M |
| March 31, 2024 | 117.59M |
| December 31, 2023 | 111.37M |
| September 30, 2023 | 112.44M |
| Date | Value |
|---|---|
| June 30, 2023 | 118.60M |
| March 31, 2023 | 121.07M |
| December 31, 2022 | 122.34M |
| September 30, 2022 | 130.95M |
| June 30, 2022 | 129.84M |
| March 31, 2022 | 139.32M |
| December 31, 2021 | 152.79M |
| September 30, 2021 | 169.30M |
| June 30, 2021 | 181.56M |
| March 31, 2021 | 82.34M |
| December 31, 2020 | 89.22M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.16M |
| Total Liabilities (Quarterly) | 7.863M |
| Current Ratio | 2.911 |
| Net Debt Paydown Yield | 42.32% |